JPMorgan says vaccine news could take the S&P 500 as high as 4,500 next year, or 24% from here

Share
People visit the Charging Bull Statue during Covid-19 pandemic in New York.
Tayfun Coskun | Anadolu Agency | Getty Images

(This story is for CNBC Pro subscribers only.)

JPMorgan said Monday's surprise vaccine news is setting the stock market up for big gains next year, seeing the potential for S&P 500 to surge as much as 24% by the end of 2021.

"The equity market is facing one of the best backdrops for sustained gains in years. After a prolonged period of elevated risks (global trade war, COVID-19 pandemic, US election uncertainty, etc.), the outlook is significantly clearing up, especially with news of a highly effective COVID-19 vaccine,"  Dubravko Lakos-Bujas, chief U.S. equity strategist at JPMorgan, said in a note on Monday.

More In Street Calls

CNBC ProBillionaire Howard Marks explains why he doesn't like gold as an investment
CNBC ProHere are the Singapore blue-chip stocks with potential for double-digit returns
CNBC ProJPMorgan says investors need to shake off 'FANG fatigue' and buy the Big Tech stocks again